Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
The “Silver Tsunami” Is Here and Gen Z Isn’t Ready to Buy
Adam Klappholz, Head of Product for Zelle, breaks down the “Silver Tsunami” as retiring boomers sell and a Gen Z buyer gap reshapes Main Street.
Why Some of America’s Richest Are Calling for Higher Taxes On Themselves
Morris Pearl of Patriotic Millionaires on why some of the wealthiest Americans are pushing for higher taxes on themselves and what it means for NYC.
How High-Altitude Platforms Could Transform Global Communications
Sceye CEO Mikkel Vestergaard on high-altitude platforms delivering connectivity and real-time environmental data from the stratosphere.
Inside The Next Chapter in Low-Earth Orbit
Dr. Jonathan Cirtain discusses Axiom Space’s plan to build Axiom Station, a commercial successor to the ISS, as the space economy expands beyond 2030.
The “World’s Oldest Intern” Speaks: William Shatner on Learning, Humility, And Starting Fresh
William Shatner and LifeWave CEO David Schmidt share lessons from his “world’s oldest intern” experience and offer advice for young professionals starting out.
The Verdict That Could Change Live Music Forever
The Live Nation ruling is in. Diana Moss of the Progressive Policy Institute joins us to unpack what it means for competition, consumers, and live music.
